Business Context and Reporting Period
Broadway Financial Corporation (BYFC) filed this Form 8-K on November 23, 2020, reporting the entry into material definitive agreements. The Company, a Delaware corporation, operates as a financial institution with principal executive offices in Los Angeles, California.
Key Financial Metrics and Transaction Details
The filing details a private placement equity transaction rather than standard operating financial results. Key metrics include:
- Aggregate Purchase Price: $11,084,149
- Price Per Share: $1.78
- Shares Issued: 4,639,888 shares of Class A Common Stock and 1,587,162 shares of Class C Common Stock (Total: 6,227,050 shares).
- Placement Fees: Approximately $221,683 payable to Raymond James & Associates, Inc. and Keefe, Bruyette & Woods, Inc.
- Investors: Cedars-Sinai Medical Center, Banc of America Strategic Investments Corporation (BofA), and Wells Fargo Central Pacific Holdings, Inc. (Wells Fargo).
Material Changes and Conditions
The transaction represents a significant capital raise structured as non-controlling equity investments. The consummation of the stock sales is subject to specific closing conditions, including:
- Completion of the previously reported merger with CFBanc Corporation.
- Receipt of required stockholder and regulatory approvals.
- Compliance with NASDAQ Listing Rules.
Upon closing, the Company's existing voting and non-voting common stock will be renamed Class A and Class C Common Stock, respectively. The Class C shares are subject to transfer restrictions to maintain their non-voting status for bank regulatory purposes.
Outlook and Additional Provisions
The Company retains the option to enter into additional stock purchase agreements with other investors for up to 12,720,000 shares of Common Stock (including the shares already agreed upon) at the same price and on similar terms. The filing notes that there can be no assurance that all closing conditions will be satisfied. The sales are exempt from registration requirements under Section 4(a)(2) of the Securities Act of 1933 or Rule 506 of Regulation D.
Investor Verification Checklist
- Verify the status of the merger with CFBanc Corporation, as the equity sale is contingent upon its consummation.
- Confirm receipt of necessary stockholder and regulatory approvals for both the merger and the private placement.
- Review the specific transfer restrictions applicable to the Class C Common Stock issued to investors.
- Monitor for potential additional equity issuances up to the maximum of 12,720,000 shares.